share_log

HC Wainwright & Co. Maintains Buy on Cartesian Therapeutics, Adjusts Price Target To $54

Moomoo 24/7 ·  Apr 23 12:26

HC Wainwright & Co. analyst Mitchell Kapoor maintains Cartesian Therapeutics (NASDAQ:RNAC) with a Buy, adjusts target to $54 from $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment